Increased biosynthesis of thromboxane A2 by diabetic platelets

European Journal of Clinical Investigation - Tập 9 Số 3 - Trang 223-228 - 1979
Vincent A. Ziboh1, Hiroyuki Maruta1, Jonathan T. Lord1, WILLIAM D. CAGLE1, WILLIAM LUCKY1
1Departments of Dermatology, Biochemistry, Obstetrics, and Gynecology, University of Miami School of Medicine, Miami, Florida, U.S.A.

Tóm tắt

Abstract. Because ADP has been reported to produce a secondary wave of platelet aggregation in diabetic subjects, and since ADP is known to enhance normal platelet biosynthesis of pro‐aggregating thromboxane A2, we tested whether or not the reported increased sensitivity of diabetic platelets to ADP may also result in increased platelet biosynthesis of thromboxane A2. To test this hypothesis, 14C‐arachidonic acid (14C‐AA) was incubated in vitro with washed human platelets' in the presence or absence of ADP. These studies included platelets isolated from thirty normal volunteers, twenty‐six diabetic subjects with and without known vascular complications, eighteen non‐diabetic pregnant females and fourteen pregnancy‐induced diabetic females. Data from these studies demonstrated: (i) a significant increase in the capability of diabetic platelets in response to ADP to biosynthesize thromboxane A2 from arachidonic acid when compared to platelets from normal controls (P < 0.001); (ii) a significant increase in thromboxane A2 biosynthesis by platelets from pregnancy‐induced diabetic subjects over nondiabetic pregnant females (P < 0.001); (iii) a two‐fold increase in thromboxane A2 biosynthesis by platelets from diabetic subjects with vascular complications when compared to those without vascular complications. Although our data also showed approximately a twofold increase in thromboxane A2 biosynthesis by platelets from diabetic subjects with greater than 10 years of the disease when compared to diabetic subjects with less than 10 years, these latter results were, however, not statistically significant. Results from these studies suggest that a relationship may exist between the markedly increased ADP‐induced platelet aggregation in diabetes mellitus and the vascular complications associated with this disease. Whether or not increased capacity of the diabetic platelet to biosynthesize pro‐aggregating thromboxane A2 in response to ADP or other pro‐aggregating agents is per se a triggering factor in occlusive vascular diseases reported in diabetic subjects must await further studies.

Từ khóa


Tài liệu tham khảo

10.1159/000387615

10.1007/BF01219463

10.7326/0003-4819-82-6-733

10.2337/diab.21.2.108

Leone G., 1974, Platelet Aggregation and Drugs, 49

10.1007/BF00422396

10.1016/S0140-6736(75)90610-8

Colwell J.A., 1976, Altered platelet function in diabetes mellitus, Diabetes, 25, 826

10.1111/j.0954-6820.1971.tb07433.x

10.2337/diabetes.24.7.684

Colwell J.A., 1973, Effect of therapy on platelet aggregation in diabetes, Clin Res, 21, 884

Smith J.B., 1970, Formation and release of prostaglandins by platelets in response to thrombin, Br J Pharmacol, 40, 545P

10.1172/JCI107262

10.1016/0005-2760(69)90001-0

Shio H., 1972, Effect of prostaglandin E2 and aspirin on the secondary aggregation of human platelets, Nature: New Biol, 236, 245

10.1111/j.1749-6632.1972.tb16287.x

10.1038/251721a0

10.1073/pnas.70.3.899

Samuelsson B., 1974, Prostaglandin Synthetase Inhibitors, 107

10.1073/pnas.71.2.345

10.1073/pnas.72.8.2994

Samuelsson B., 1976, Prostaglandin endoperoxides and thromboxanes in platelet aggregation, Adv Prostaglandin Thromboxane Res, 2, 737

10.1056/NEJM197712152972402

Ziboh V.A., 1973, Biosynthesis of prostaglandin E2 in human skin: subcellular localization and inhibition by unsaturated fatty acids and anti‐inflammatory drugs, J Lipid Res, 14, 377, 10.1016/S0022-2275(20)36869-3

10.1172/JCI104970

Lowry O.H., 1951, Protein measurement with the folin phenol reagent, J Biol Chem, 193, 163, 10.1016/S0021-9258(19)52451-6

10.1016/0090-6980(77)90026-0

10.1038/newbio231232a0

Smith J.B., 1970, Aspirin selectively inhibits prostaglandin production in human platelets, Nature: New Biol, 231, 235

10.1001/jama.1939.02800260029008

10.2105/AJPH.55.3.416

10.1056/NEJM197712152972408

Thông tin
Thông tin xuất bản

European Journal of Clinical Investigation

Tập 9 Số 3

223-228

Thông tin tác giả